Pfizer
Trade Pfizer 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About PFE
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases.
PFE Key Statistics
Stock Snapshot
With a market cap of 142.66B, Pfizer(PFE) trades at $25.07. The stock has a price-to-earnings ratio of 19.28 and currently yields dividends of 6.84%.
During the trading session on 2026-07-31, Pfizer(PFE) shares reached a daily high of $25.18 and a low of $24.67. At a current price of $25.07, the stock is +1.6% higher than the low and still -0.4% under the high.
Trading volume for Pfizer(PFE) stock has reached 45.07M, versus its average volume of 36.81M.
The stock's 52-week range extends from a low of $23.11 to a high of $28.75.
The stock's 52-week range extends from a low of $23.11 to a high of $28.75.
PFE News
Key Points Pfizer's financial results haven't been great, and upcoming patent cliffs could exacerbate the problem. However, the company's large pipeline acros...
In late July 2026, Pfizer reported positive Phase 3 results for its oral JAK3/TEC inhibitor LITFULO in nonsegmental vitiligo and secured European Commission app...
Pfizer Inc (PFE) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more confident inv...
Analyst ratings
62%
of 29 ratingsMore PFE News
The trials demonstrated that the medication provided significant improvements for patients suffering from both active and stable forms of the condition across a...
Pfizer (PFE) announced topline results from two Phase 3 trials evaluating the efficacy and safety of LITFULO once daily in patients with both active and stable...
Pfizer stock sits in an awkward middle ground today. The shares have fallen about 28% over the past five years, yet recent gains and a mixed valuation score sug...
Pfizer Inc (PFE) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more confident inv...
In a report released yesterday, Terence Flynn from Morgan Stanley maintained a Hold rating on Pfizer, with a price target of $28.00. Claim 55% Off TipRanks Unlo...
Pfizer (PFE) is back in focus after the FDA accepted a Priority Review for its supplemental New Drug Application for TALZENNA plus XTANDI in metastatic castrati...
Key Points Pfizer is a large and well-respected pharmaceutical company. Pfizer has been facing headwinds, leaving investors worried about the dividend. The b...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.